Martin Moik

695 total citations
10 papers, 256 citations indexed

About

Martin Moik is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Martin Moik has authored 10 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Martin Moik's work include Cancer Genomics and Diagnostics (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Renal cell carcinoma treatment (4 papers). Martin Moik is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Renal cell carcinoma treatment (4 papers). Martin Moik collaborates with scholars based in Austria, Germany and United States. Martin Moik's co-authors include Richard Greil, I G Schmidt-Wolf, K. Weigang-Köhler, Hanno Riess, Helmut Oettle, Caroline Hammer, Martina Stauch, Clemens Hufnagl, A. Helm and Marco Niedergethmann and has published in prestigious journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment and Neuro-Oncology.

In The Last Decade

Martin Moik

10 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martin Moik Austria	8	164	120	77	55	53	10	256
Emanuela Romagnoli Italy	7	188 1.1×	56 0.5×	85 1.1×	90 1.6×	16 0.3×	16	279
Huiyu Lu China	11	144 0.9×	76 0.6×	82 1.1×	120 2.2×	9 0.2×	29	303
Ya-Ching Hsieh United Kingdom	9	90 0.5×	40 0.3×	33 0.4×	105 1.9×	41 0.8×	12	268
Valentina Polo Italy	10	100 0.6×	55 0.5×	130 1.7×	66 1.2×	32 0.6×	33	242
Eriseld Krasniqi Italy	10	197 1.2×	99 0.8×	95 1.2×	93 1.7×	12 0.2×	21	342
Vincenzo Famiglietti Italy	9	219 1.3×	60 0.5×	92 1.2×	55 1.0×	20 0.4×	27	281
Rumi Higuchi Japan	11	96 0.6×	81 0.7×	139 1.8×	62 1.1×	9 0.2×	26	297
Isabella Bergagnini United States	8	191 1.2×	79 0.7×	179 2.3×	134 2.4×	21 0.4×	18	379
Shengnan Luo China	9	178 1.1×	76 0.6×	74 1.0×	138 2.5×	9 0.2×	18	370
Augusto Bleve Italy	6	99 0.6×	75 0.6×	36 0.5×	103 1.9×	9 0.2×	8	274

Countries citing papers authored by Martin Moik

Since Specialization

Citations

This map shows the geographic impact of Martin Moik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Moik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Moik more than expected).

Fields of papers citing papers by Martin Moik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Moik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Moik. The network helps show where Martin Moik may publish in the future.

Co-authorship network of co-authors of Martin Moik

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Moik. A scholar is included among the top collaborators of Martin Moik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Moik. Martin Moik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Hufnagl, Clemens, Michael Leisch, Lukas Weiß, et al.. (2019). Evaluation of circulating cell‑free DNA as a molecular monitoring tool in patients with metastatic cancer. Oncology Letters. 19(2). 1551–1558. 13 indexed citations

2.

Melchardt, Thomas, Teresa Magnes, Lukas Weiß, et al.. (2014). Liver toxicity during temozolomide chemotherapy caused by Chinese herbs. BMC Complementary and Alternative Medicine. 14(1). 115–115. 16 indexed citations

3.

Hufnagl, Clemens, Markus Stöcher, Martin Moik, Roland Geisberger, & Richard Greil. (2013). A modified Phenol-chloroform extraction method for isolating circulating cell free DNA of tumor patients. 4(1). 1–1. 3 indexed citations

4.

Hutterer, Markus, Martha Nowosielski, Johannes Haybaeck, et al.. (2013). A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07). Neuro-Oncology. 16(1). 92–102. 62 indexed citations

5.

Hufnagl, Clemens, Markus Stöcher, Martin Moik, Roland Geisberger, & Richard Greil. (2013). A modified Phenol-chloroform extraction method for isolating circulating cell free DNA of tumor patients. 4(1). 1–1. 25 indexed citations

6.

Mlineritsch, Brigitte, et al.. (2011). Efficacy of Temsirolimus after Previous Treatment with Sunitinib, Sorafenib or Everolimus in Advanced Renal Cell Cancer. Oncology. 80(1-2). 34–41. 4 indexed citations

7.

Mlineritsch, Brigitte, Johannes Andel, Michael Fridrik, et al.. (2009). Multicenter Phase II Study of Pegylated Liposomal Doxorubicin in Combination with Vinorelbine as First-Line Treatment in Elderly Patients with Metastatic Breast Cancer. Oncology Research and Treatment. 32(1-2). 18–24. 12 indexed citations

8.

Greil, Richard, Martin Moik, Roland Reitsamer, et al.. (2009). Neoadjuvant bevacizumab, docetaxel and capecitabine combination therapy for HER2/neu-negative invasive breast cancer: Efficacy and safety in a phase II pilot study. European Journal of Surgical Oncology. 35(10). 1048–1054. 28 indexed citations

9.

Mlineritsch, Brigitte, et al.. (2007). Fulvestrant (‘Faslodex’) in heavily pretreated postmenopausal patients with advanced breast cancer: single centre clinical experience from the compassionate use programme. Breast Cancer Research and Treatment. 106(1). 105–112. 13 indexed citations

10.

Riess, Hanno, A. Helm, Marco Niedergethmann, et al.. (2005). A randomised, prospective, multicenter, phase III trial of gemcitabine, 5-fluorouracil (5-FU), folinic acid vs. gemcitabine alone in patients with advanced pancreatic cancer. Journal of Clinical Oncology. 23(16_suppl). LBA4009–LBA4009. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact